BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3102089)

  • 1. Cyclophosphamide versus ifosfamide: preliminary report of a randomized phase II trial in adult soft tissue sarcomas.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Thomas D; Sylvester R; Van Oosterom A
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S13-6. PubMed ID: 3102089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verwey J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):311-21. PubMed ID: 3595691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group.
    Pawinski A; Tumolo S; Hoesel G; Cervantes A; van Oosterom AT; Boes GH; Pecorelli S
    Eur J Obstet Gynecol Reprod Biol; 1999 Oct; 86(2):179-83. PubMed ID: 10509788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response.
    Ruymann FB; Vietti T; Gehan E; Wiener E; Wharam M; Newton WA; Maurer H
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):331-7. PubMed ID: 7583389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS).
    Buesa JM; López-Pousa A; Martín J; Antón A; García del Muro J; Bellmunt J; Arranz F; Valentí V; Escudero P; Menéndez D; Casado A; Poveda A
    Ann Oncol; 1998 Aug; 9(8):871-6. PubMed ID: 9789610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
    Stuart-Harris RC; Harper PG; Parsons CA; Kaye SB; Mooney CA; Gowing NF; Wiltshaw E
    Cancer Chemother Pharmacol; 1983; 11(2):69-72. PubMed ID: 6414732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.
    Patel SR; Vadhan-Raj S; Papadopolous N; Plager C; Burgess MA; Hays C; Benjamin RS
    J Clin Oncol; 1997 Jun; 15(6):2378-84. PubMed ID: 9196153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
    van Oosterom AT; Mouridsen HT; Nielsen OS; Dombernowsky P; Krzemieniecki K; Judson I; Svancarova L; Spooner D; Hermans C; Van Glabbeke M; Verweij J;
    Eur J Cancer; 2002 Dec; 38(18):2397-406. PubMed ID: 12460784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
    Antman KH; Ryan L; Elias A; Sherman D; Grier HE
    J Clin Oncol; 1989 Jan; 7(1):126-31. PubMed ID: 2491883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.
    Antman KH; Montella D; Rosenbaum C; Schwen M
    Cancer Treat Rep; 1985 May; 69(5):499-504. PubMed ID: 3924401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J; Kellner R; Seeber S
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas.
    Palumbo R; Palmeri S; Antimi M; Gatti C; Raffo P; Villani G; Toma S
    Ann Oncol; 1997 Nov; 8(11):1159-62. PubMed ID: 9426338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study.
    Palumbo R; Palmeri S; Gatti C; Villani G; Cesca A; Toma S
    Oncol Rep; 1998; 5(1):69-72. PubMed ID: 9458296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas.
    Marina NM; Poquette CA; Cain AM; Jones D; Pratt CB; Meyer WH
    J Pediatr Hematol Oncol; 2000; 22(2):112-8. PubMed ID: 10779023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide in advanced carcinoma of the esophagus: a phase II trial with severe toxicity.
    Ansell SM; Alberts AS; Falkson G
    Am J Clin Oncol; 1989 Jun; 12(3):205-7. PubMed ID: 2499176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R; Dalley D; Bell DR; Levi J; Simes RJ; Wiltshaw E
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas.
    Skubitz KM; Hamdan H; Thompson RC
    Cancer; 1993 Nov; 72(10):2963-9. PubMed ID: 8221562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH; Wen XP; Hu L
    Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people.
    Magrath I; Sandlund J; Raynor A; Rosenberg S; Arasi V; Miser J
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S25-8. PubMed ID: 3815717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.